Public Health Intervention Framework for Reviving Economy Amid the COVID-19 Pandemic (1): A Concept

Jianqing Wu, Ping Zha


The COVID-19 pandemic has great adverse impacts on personal life, the U.S. economy, and the world economy. Freezing all human activities is not a sustainable measure. Thus we want to develop a public intervention framework that allows people to resume personal and economic activities. In this article, we examined transmission routes, disease severity, personal vulnerability, available treatments, and person-person interactions to establish a general public intervention framework. We divide people into risk groups, non-risk group and group that may serve as viral transmitters, explore interactions between individual persons within each group and between different groups, and propose interaction behavior modifications to mitigate viral exposures. For the non-risk groups, we identified preventive measures that can help them avoid the most serious exposures and infections that pose higher death risks. The invention measures for the vulnerable groups include prior-exposure mitigating measures, heightened protective measures, interaction behavior changes, post-exposure remedial measures, and multiple factors treatments to reduce death and disability risks. The multiple interventions and two-way defensive behavior modifications are expected to result in reduced rate of detectable infections and lowered disease severity for the vulnerable groups. In this framework, most human activities and economic activities can continue as normal. With time passing, the population acquires population immunity against the COVID-19 virus. Implementation of this intervention framework requires considerable resources and governmental effects while the multiple-factor treatment protocol requires the support of health care professionals.

Full Text:



WHO, Coronavirus disease 2019 (COVID-19) Situation Report – 78 Data as reported by national authorities by 10:00 CET 7 April 2020. Accessed at

Coronavirus Cases: United States, Last updated: April 07, 2020, 20:31 GMT. Accessed at

Goldstein S. Morgan Stanley releases new forecast showing U.S. economy may drop as much as 38%. April 3, 2020. Accessed at

Associated Press. (Thu 2 Apr 2020) Coronavirus outbreaks like 'wildfire' at US nursing homes under lockdowns. Measures including a ban on visits and daily health screenings of staffers either came too late or were not rigorous enough. Accessed at

Thompson D. Why Will It Take So Long for a COVID-19 Vaccine? April 6, 2020, HealthDay News. Accessed at

Abdul-Rasool S, Fielding BC. Understanding Human Coronavirus HcoV-NL63. Open Virol J. 2010;4:76–84.

Domingo E, Holland JJ. RNA Virus Mutations and Fitness for Survival, Annual Review of Microbiology. 1997;51:151–78.

Yang Y, Yang M, Shen C, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv preprint doi:

Ma J, Lew L, Jeong-ho L. (22 Mar, 2020) A third of coronavirus cases may be ‘silent carriers’, classified Chinese data suggests. . South China Morning Post. Accessed at

Hein A. Maryland nursing home coronavirus outbreak may have started with asymptomatic staffer, gov says. Fox News. April 2, 2020. Accessed at

CDC. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. The report was posted online on March 18, 2020 as an MMWR Early Release. Weekly/March 26, 2020/69(12);343-346.

Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020. Published Online March 30, 2020. online March 30, 2020 Doi: 10.1016/S1473-3099(20)30243-7.

Lilienfeld AM. Practical Limitations of Epidemiologic Methods. Environmental Health Perspectives.1983;52:3-8.

Wu, JQ and Zha, P. Randomized Clinical Trial Is Biased and Invalid In Studying Chronic Diseases, Compared with Multiple Factors Optimization Trial (November 4, 2019). Available at SSRN: or doi: 10.2139/ssrn.3480523

Tang B, Wang X, Li Q. et al. Estimation of the transmission risk of 2019-nCov and its implication for public health interventions. Electronic copy available at:

Wu JQ, Zha P. Treatment Strategies for Reducing Damages to Lungs in Coronavirus and Other Lung Infections (February 6, 2020). Available at SSRN: Doi: 10.2139/ssrn.3533279

Wu JQ, Zha P. Preventive, Mitigating and Treatment Strategies for Containing or Ending the COVID-19 Pandemic (a first update) (February 25, 2020). Available at SSRN: Doi: 10.2139/ssrn.3544428.

Wu JQ, Zha P. Association of COVID-19 Disease Severity with Transmission Routes and Suggested Changes to Community Guidelines (March 13, 2020). Available at SSRN: Doi: 10.2139/ssrn.3554043.

Wu JQ, Zha P. Mask Is a Double-edged Sword in the Fight Against COVID-19 Pandemic (March 28, 2020). Available at SSRN: Doi: 10.2139/ssrn.3563851

Ellis E, Delbruck M. The Growth of Bacteriophage. The Journal of General Physiology. 1939;22(3):365–384.

Zwart MP, Hemerik L, Jenny S, et al. An experimental test of the independent action hypothesis in virus–insect pathosystems. Proc. R. Soc. B 2009;276:2233–2242.

Leeks A, Sanjuán R, West SA. The evolution of collective infectious units in viruses. Virus Res. 2019 May;265:94–101.

Vignuzzi M, Stone JK, Arnold JJ, et al. Quasispecies Diversity Determines Pathogenesis Through Cooperative Interactions in a Viral Population, Nature, 2006;439:344–8.

Shirogane Y, Watanabe S, Yanagi Y. Cooperation between different variants: A unique potential for virus evolution. Virus Res. 2019 Apr 15;264:68-73.

Leeks A, Segredo-Otero EA, Sanjuán R, West SA. Beneficial coinfection can promote within-host viral diversity. Virus Evol. 2018;4/2.

Weibel ER. On the Tricks Alveolar Epithelial Cells Play to Make a Good Lung. Am J Respir Crit Care Med. 2015;191(5):504–513.

Fabian P, McDevitt JJ, DeHaan WH. Influenza virus in human exhaled breath: an observational study. PLoS One 2008,3, e2691.

Stelzer-Braid S, Oliver BG, Blazey AJ, et al. Exhalation of respiratory viruses by breathing, coughing, and talking. J Med Virol. 2009B;81:1674–1679.

Lindsley WG, Blachere FM, Thewlis RE, et al. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS ONE. 2010;5:e15100.

Milton DK, Fabian MP, Cowling BJ, et al. Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS pathogens. 2013;9:e1003205.

Lindsley WG, Pearce TA, Hudnall JB, et al. Quantity and size distribution of cough-generated aerosol particles produced by influenza patients during and after illness. J Occup Environ Hyg. 2012;9:443–449.

Coleman KK, Sigler WV. Airborne Influenza A Virus Exposure in an Elementary School. Scientific Reports. 2020;10,1859.

Alonso C, Goede DP, Morrison RB, et al. Evidence of infectivity of airborne porcine epidemic diarrhea virus and detection of airborne viral RNA at long distances from infected herds. Vet Res. 2014 Jul 14;45:73. Doi: 10.1186/s13567-014-0073-z.

Alonso C, Raynor PC, Goyal S, et al. Assessment of air sampling methods and size distribution of virus-laden aerosols in outbreaks in swine and poultry farms. Journal of Veterinary Diagnostic Investigation. 2017;29(3) 298–304.

Arruda AG, Tousignant S, Sanhueza J, et al. Aerosol Detection and Transmission of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): What Is the Evidence, and What Are the Knowledge Gaps? Viruses. 2019 Aug 3; 11(8). Epub 2019 Aug 3.

Corzo CA, Culhane M, Dee S, et al. Airborne Detection and Quantification of Swine Influenza A Virus in Air Samples Collected Inside, Outside and Downwind from Swine Barns. PLoS One. 2013 Aug 8;8(8):e71444.

Alonso C, Raynor PC, Davies PR, Torremorell M. Concentration, Size Distribution, and Infectivity of Airborne Particles Carrying Swine Viruses. PLoS One. 2015 Aug 19;10(8):e0135675. Doi: 10.1371/journal.pone.0135675. ECollection 2015.

Hall CB. Nosocomial viral respiratory infections: perennial weeds on pediatric wards. Am J Med. 1981;70:670–676.

Hall CB, Douglas RG, Jr, Geiman JM, Meagher MP. Viral shedding patterns of children with influenza B infection. J Infect Dis. 1979;140:610–613.

Frank AL, Taber LH, Wells CR, et al. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis. 1981;144:433–441.

Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med. 2003;348:867–868.

Sato M, Hosoya M, Kato K, Suzuki H. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J. 2005;24:931–932.

Glezen WP. Influenza control. N Engl J Med. 2006;355:79–81.

Westphalen K, Gusarova GA, Islam MN, et al. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature. 2014;506(7489):503–6.

Kirby AC, Coles MC, Kaye PM. Alveolar macrophages transport pathogens to lung draining lymph nodes. J Immunol. 2009;183(3):1983–9.

Bhattacharya J, Westphalen K. Macrophage-epithelial interactions in pulmonary alveoli. Semin Immunopathol. 2016 Jul; 38(4):461–469.

Rodero MP, Poupel L, Loyher P-L, et al. Immune surveillance of the lung by migrating tissue monocytes. eLife 2015;4:e07847. DOI: 10.7554/eLife.07847

Coronavirus disease (COVID-19) advice for the public: When and how to use masks.

CDC. How to Protect Yourself, Accessed at Last Access on March 28, 2020.

Qualls N, Levitt A, Kanade N, et al. Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017. Carrie Reed MMWR Recomm Rep. 2017 Apr 21; 66(1): 1–32. Doi: 10.15585/mmwr.rr6601a1.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.